Influence of high fat diet (butter) on the pharmacokinetics of phenytoin and carbamazepine

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 26, Issue 8, 2004, Pages 635-638

  Sidhu, S ^a   Malhotra, Samir ^a   Garg, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Butter; Carbamazepine; Pharmacokinetics; Phenytoin

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; ANTICONVULSIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BUTTER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FOOD DRUG INTERACTION; LIPID DIET; MALE; NONHUMAN; PLASMA; RABBIT; ABSORPTION; ANIMAL; AREA UNDER THE CURVE; BIOAVAILABILITY; BLOOD;

ABSORPTION; ANIMALS; ANTICONVULSANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BUTTER; CARBAMAZEPINE; CROSS-OVER STUDIES; FOOD-DRUG INTERACTIONS; MALE; PHENYTOIN; RABBITS;

EID: 16644399987     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2004.26.8.863730     Document Type: Article

References (18)

1. th Edition. Braunwald, E., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L., Jameson, J.L. (Eds.). McGraw Hill 2001, 2354-69.
2. Gugler, R., Manion, C.V., Azarnoff, D.L. Phenytoin: Pharmacokinetics and bioavailability. Clin Pharmacol Ther 1975, 19: 135-42.
3. Perucca, E., Richens, A. Antiepileptic drugs: Clinical aspects. In: Therapeutic Drug Monitoring. Richens and Marks (Eds.). Churchill Livingstone: Edinburgh 1981, 320-44.
4. Merrew, J.I., Richens, A. Disposition of anticonvulsants in childhood. Clin Pharmacokinet 1989,17 (Suppl 1): 89-104.
5. Arnold, K., Gerber, N., Levy, G. Absorption and dissolution studies in sodium diphenylhydantoin capsules. Can J Pharm Sci 1970, 5: 89-92.
6. Tyrer, J.H., Eadic, M.J., Sutherland, J.M., Hooper, W.D. Outbreak of anticonvulsant intoxication in Australian city. Br Med J 1970, 4: 271-3.
7. Dickinson, R.G., Hooper, W.D., Patternson, M., Eadie, M. Extent of urinary excretion of hydroxyl-phenytoin in healthy subjects given phenytoin. Ther Drug Monitoring 1985, 7: 283-9.
8. Anne, M., Richars, A. Effect of single doses of sodium valporate on serum phenytoin levels and on protein bindings in epileptic patients. Clin Pharmacol Ther 1980, 27: 89-95.
9. Kutt, H. Interactions between anticonvulsants and other commonly prescribed drugs. Epilepsia 1984, 25 (Suppl. 2): S118-31.
10. Bertilsson, L., Tomson, L. Clinical pharmacokinetics and pharmacological effects of Carbamazepine and Carbamazepine-10, 11 epoxide. An update. Clin Pharmacokinet 1986, 11: 177-98.
11. Levy, R.H., Pitlick, W.H., Troupin, A.S., Green, J.R., Near, J.M. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 1975, 17: 657-68.
12. Eichelbaum, M., Exbom, K., Bertilsson, L., Ringberger, V.A., Rane, A. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur J Clin Pharmacol 1975, 8: 337-48.
13. Doose, D.R., Salker, S.A., Gission, L.G., Nayak, R.K. Single dose pharmacokinetics of food on the bioavailability of Tapiramate, a novel antiepileptic drug. J Clin Pharmacol 1996, 36: 884-91.
14. Eichelbaum, M., Tomson, T., Tybring, G., Bertillson, L. Carbamazepine metabolism in man: Induction and pharmacogenetic aspects. Clin Pharmacokinetic 1985, 10: 80-90.
15. Degen, P.H., Flesch, G., Cardot, J.M., Czendlik, C., Dieterle, W. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharm Drug Dispos 1994, 15: 519-26.
16. Macheras, P., Ismailos, G., Reppas, C. Bioavailability study of a freeze dried sodium phenytoin-milk formulation. Biopharm Drug Dispos 1991,9: 687-95.
17. Zhi, J., Rakhil, A., Patel, I.H. Effect of dietary fat on drug absorption. Clin Pharmacol Ther 1995, 38: 487-91.
18. Vessll, E.S. Complex effects of diet on drug disposition. Clin Pharmacol Ther 1984, 36: 285-96.